Our Quest

QuantalX Neuroscience is a medical device company established by neuroscientists who are committed to revolutionizing the current approach of brain health diagnosis. Together with a dedicated team of developers, scientists, physicians, and business leaders we tackle the clinical, economic, and operational challenges leading to late diagnosis and misdiagnosis of neurodegenerative diseases. The Delphi-MD device, powered by our cutting-edge technology, embodies our vision that early diagnosis and access to brain function are crucial in dealing with the significant challenges posed by brain disorders. Our mission is to transform brain health and disease care, steering in a new era of treatment and support.

An Experienced Team

Dr. Kobi Richter

Iftach Dolev, PhD

CEO and Founder

Dr. Kobi Richter

Hilla Fogel, PhD

CTO and Founder

Dr. Kobi Richter

Prof. David Tanne, MD

Medical Director

Dr. Kobi Richter

Adam Hazima

VP Operations

Dr. Kobi Richter

Ofri Levy Lamdan, PhD

VP Research & Development

Dr. Kobi Richter

Noa Zifman Mozni

VP Clinical & Regulatory

Scientific and Medical Advisors

Dr. Kobi Richter

Col. Dallas C. Hack, MD

Dr. Kobi Richter

Philip B. Gorelick,MD, MPH

Dr. Kobi Richter

Richard E. Kuntz, MD

Board Members

Dr. Kobi Richter

Israel Makov

Chairman of the Board

Dr. Kobi Richter

Kobi Richter, PhD

Board Member

Dr. Kobi Richter

Ehud Barak

Board Member

Dr. Kobi Richter

Mike Netz

Active Board Member

Dr. Kobi Richter

Doron Livnat

Board Member

Want to Impact Brain Health?

Join us: careers@QuantalX.com

Skip to content